Lim Sl Ki, Lim Jacqueline Kyungah, Yoon In Kyu
International Vaccine Institute, Seoul, Korea.
Infect Chemother. 2017 Jun;49(2):91-100. doi: 10.3947/ic.2017.49.2.91.
Zika virus (ZIKV) was first isolated in Asia from mosquitoes from Malaysia in 1966. However, the incidence of Zika and Zika-related neurological complications in Asia is not well known. The few studies of Zika in Asia have been inconsistent in pointing to likely transmission levels, with some studies suggesting substantial transmission and others not. Interpretation of existing epidemiological and public health data from Asia is constrained by the non-specific symptomatology of Zika, the high proportion of subclinical ZIKV infections, relatively low viremia, and the lack of accurate serological assays. Here, we update the status of Zika cases from countries in Asia, and highlight some key knowledge gaps. In particular, accurate determinations of the incidence of Zika-related congenital Zika syndrome should be a priority for Zika research in Asia. Additional information will be critical to make informed strategies for the prevention and control of this global public health threat.
寨卡病毒(ZIKV)于1966年首次在亚洲从马来西亚的蚊子中分离出来。然而,亚洲寨卡病毒感染率以及与寨卡病毒相关的神经并发症情况尚不清楚。亚洲对寨卡病毒的少数研究在指出可能的传播水平方面并不一致,一些研究表明传播率很高,而另一些研究则不然。对来自亚洲的现有流行病学和公共卫生数据的解读受到寨卡病毒非特异性症状、亚临床寨卡病毒感染比例高、病毒血症相对较低以及缺乏准确血清学检测方法的限制。在此,我们更新了亚洲各国寨卡病例的现状,并强调了一些关键的知识空白。特别是,准确确定与寨卡病毒相关的先天性寨卡综合征的发病率应成为亚洲寨卡病毒研究的优先事项。更多信息对于制定明智的预防和控制这一全球公共卫生威胁的策略至关重要。